ARDM
Aradigm Corporation
A specialty pharmaceutical company that designed inhalable drug delivery systems, crafting medicines that let patients breathe treatments for respiratory conditions like bronchiectasis and cystic fibrosis directly into their lungs. Founded in 1991 in Hayward, California, the company developed inhaled antibiotic therapies such as Pulmaquin and Linhaliq. Its name is a play on "paradigm," hinting at a shift in how lung medicines are delivered.
CUSIP: 038505400HealthcareUS1 holder